VOLTARENDOLO

Opinions on drugs - Posted on May 16 2014

Re-assessment of the Actual Benefit of all medicines based on

Substantial	The actual benefit of this proprietary medicinal product in this indication remains substantial.
Insufficient	The actual benefit of this proprietary medicinal product in this indication remains insufficient in the sub-population of patients with risk factors for a cardiovascular event.